|
|
On The Cover
An Industry Overview
Life-sciences companies will have to transform themselves into more nimble, forward-thinking entities.
By Robin Robinson And Denise Myshko
Features
At A Glance
Industry experts provide highlights of the trends covered in this issue.
Crystal Ball
Industry experts identify the top trends they expect to shape the industry.
The Corner Office
Comments from CEOs and Presidents of leading life-sciences companies reveal strategies and top trends for the coming year.
Globalization
Emerging markets provide opportunities for pharmaceutical companies as well as their partners.
By Taren Grom, Editor
Counterfeit Drugs
The counterfeit medicines market is a real, clear, and present danger to public health.
By Denise Myshko
Early Research
Discovery and research technologies will have a tremendous impact on the pipelines of the future.
By Denise Myshko
Development
Successful biopharmaceutical companies will be those that review R&D business models and implement updated strategies.
By Denise Myshko
Personalized Medicine
Obstacles and challenges still remain to make the vision of personalized medicine a reality.
By Denise Myshko
Patient Recruitment
Larger, more complex trials have made the enrollment of patients even more challenging.
By Denise Myshko
Salesforces
The industry will employ innovative ways to do more with less and add a value proposition to sales strategies.
By Robin Robinson
Marketing
Pharma begins the move from informing to interacting amid the Web 2.0 revolution.
By Robin Robinson
Patient Education
Product managers still need to reach patients with messages that resonate on a personal level.
By Taren Grom, Editor
Doctors’ Choice Awards
A review of the 2008 winners.
|
|
